The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.


Time/Date Code Headline Source Impact
07:00 04-Apr-2018 IXI Agreement RNS -1.84% Down
07:00 30-Jan-2018 IXI New contract in progressive supranuclear palsy RNS +9.47% Up
15:16 22-Jan-2018 IXI Result of AGM RNS +1.94% Up
07:00 22-Jan-2018 IXI AGM Statement and Board Changes RNS +1.94% Up
07:00 11-Dec-2017 IXI Final Results RNS -7.52% Down
07:00 28-Nov-2017 IXI Strategic and Operational Update RNS +1.23% Up
07:00 16-Nov-2017 IXI Contract to Deploy Biosensors in Clinical Trial RNS -2.94% Down
10:14 19-Oct-2017 IXI Trading Statement RNS +2.99% Up
07:00 04-Oct-2017 IXI New contract to support Phase II clinical trial RNS -
07:00 28-Sep-2017 IXI New contract in Huntington's disease RNS -
07:00 25-Sep-2017 IXI New Contract with Biopharmaceutical Company RNS +2.12% Up
07:00 05-Sep-2017 IXI Extension of a 5 year contract RNS +5.69% Up
16:23 08-Aug-2017 IXI Director/PDMR Shareholding RNS -0.88% Down
07:00 24-Jul-2017 IXI Expansion of Collaboration with Biogen RNS +3.13% Up
07:00 18-Jul-2017 IXI IXICO hosts Alzheimer Expert Symposium RNS -
07:00 05-Jul-2017 IXI New contract for imaging clinical trial services RNS +10.34% Up
07:00 22-May-2017 IXI Half Yearly Report to 31 March 2017 RNS +4.92% Up
09:57 16-May-2017 IXI Notice of H1 Results RNS +0.66% Up

Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released
y = instrument's latest 7 closing prices before the news was released, including the day of the release of the news

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank “ - “ next to the line indicating the RNS issue.


Company Information
Updated Monthly
Company address 4th Floor, Griffin Court, 15 Long Lane, London, EC1A 9PN, United Kingdom
Company website
Market cap(in millions)* £ 9.36
Listing/Admission to trading 15 Oct 2013
Trading service SETSqx
Market AIM
Listing category -
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
FTSE index FTSE AIM All-Share,FTSE AIM All-Share - Health Care
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Biotechnology
Country of share register GB
Segment ASQ1
MiFID Status -
Exchange market size 1,000
ISIN number GB00BCLY7L40

IXICO share news analysis (IXI)